Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Blood|December 9, 1998
Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factorC Menetrier-Caux, G Montmain, M C Dieu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 15, 2009
Amphiregulin promotes resistance to gefitinib in nonsmall cell lung cancer cells by regulating Ku70 acetylationBenoît Busser, Lucie Sancey, Véronique Josserand, et al.
Diabetes & Metabolism|January 30, 2007
MnTMPyP, a metalloporphyrin-based superoxide dismutase/catalase mimetic, protects INS-1 cells and human pancreatic islets from an in vitro oxidative challengeC Moriscot, S Candel, V Sauret, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Evaluation of CD44 prognostic value in neuroblastoma: comparison with the other prognostic factorsV Combaret, C Lasset, D Frappaz, et al.
British Journal of Haematology|September 1, 1986
Bone marrow purging procedure in Burkitt lymphoma with monoclonal antibodies and complement: quantification by a liquid cell culture monitoring systemM C Favrot, I Philip, T Philip, et al.
Veterinary Microbiology|February 3, 2009
Sequence and classification of FdPV2, a papillomavirus isolated from feline Bowenoid in situ carcinomasC E Lange, K Tobler, T Markau, et al.
Cancer Research|December 1, 1996
Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and act as cooperative growth factorsN Voorzanger, R Touitou, E Garcia, et al.
Blood Reviews|June 1, 1991
Management of pediatric non-Hodgkin's lymphomaJ Y Blay, D Louis, E Bouffet, et al.
International Journal of Cancer|April 10, 1995
Sensitive detection of numerical and structural aberrations of chromosome 1 in neuroblastoma by interphase fluorescence in situ hybridization. Comparison with restriction fragment length polymorphism and conventional cytogenetic analysesV Combaret, C Turc-Carel, P Thiesse, et al.
Molecular Biotherapy|March 1, 1990
Lymphokine-activated killer cell expansion for clinical trials of adoptive immunotherapy with interleukin-2: optimization of the culture techniqueM C Favrot, C Coze, V Combaret, et al.
Pageof 9